Cost-Effectiveness and Budget Impact Analysis of the Use of Faricimab in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration in Colombia
Daniel Samacá-Samacá, Antonio Robles, Hugo Hernán Ocampo, Francisco J. Rodríguez, Carolina Sardi, Laura Prieto‐Pinto, Christian Bührer, Camilo Tamayo, David Rodriguez, Mauricio Hernández-Quintana
- ISSN / E-ISSN
- — / —
- DOI
- 10.36469/001c.129832 ↗
- Volume · Issue · Pages
- 12 · 1 · 97-105
- Publisher
- Columbia Data Analytics, LLC
- Article URL
- https://doi.org/10.36469/001c.129832 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
01 Jan 2025
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 01 Jan 2025 | OpenAlex |
Keywords (as given): faricimab; diabetic macular edema; neovascular age-related macular degeneration; cost-effectiveness; budget impact; treat-and-extend regimen; aflibercept; ranibizumab; brolucizumab; anti-VEGF therapy; quality-adjusted life years; retinal disease; Colombia; healthcare resource allocation; drug costs; administrative costs
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- Some rows of the HEC list for this period are not yet matched to a journal, so absence cannot be proved. Pending verification.
Best available information, not a definitive status: Some rows of the HEC list for this period are not yet matched to a journal, so absence cannot be proved. Pending verification.
- Journal
- Journal of Health Economics and Outcomes Research
- Publication date used
- 01 Jan 2025 (OpenAlex publication date)
- Applicable HEC period
- 2024–25 (version 1) · 01 Oct 2024 – 31 Mar 2026
- Category
- —
- Recognition status
- Pending Verification (PERIOD_HAS_UNMATCHED_ROWS)
- Source
- —
- Verification status
- Unverified
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.